Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sevasti B Koukouritaki

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Pharmacogenomics|November 22, 2005
Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug developmentSevasti B Koukouritaki, Ronald N Hines
Drug Metabolism Reviews|May 9, 2008
Regulatory polymorphisms and their contribution to interindividual differences in the expression of enzymes influencing drug and toxicant dispositionRonald N Hines, Sevasti B Koukouritaki, Mark T Poch, et al.
Pediatric Research|January 26, 2002
Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expressionSevasti B Koukouritaki, Pippa Simpson, Catherine K Yeung, et al.
Molecular Pharmacology|April 29, 2005
Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variantsSevasti B Koukouritaki, Mark T Poch, Erwin T Cabacungan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 23, 2003
Human hepatic CYP2E1 expression during developmentElizabeth K Johnsrud, Sevasti B Koukouritaki, Karthika Divakaran, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2003
Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6)Ronald N Hines, Zhaohui Luo, Kathleen A Hopp, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 17, 2003
Developmental expression of the major human hepatic CYP3A enzymesJeffrey C Stevens, Ronald N Hines, Chungang Gu, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 25, 2003
Developmental expression of human hepatic CYP2C9 and CYP2C19Sevasti B Koukouritaki, Jason R Manro, Sandra A Marsh, et al.
The Journal of Biological Chemistry|February 5, 2025
Phosphorylation of distal C-terminal residues promotes TRPV4 channel activation in response to arachidonic acidAravind Parthasarathy, Andriy Anishkin, Yangjing Xie, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2011
Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogsJuan Fang, Eric S Jensen, Mary K Boudreaux, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|November 22, 2005
Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug developmentSevasti B Koukouritaki, Ronald N Hines
Drug Metabolism Reviews|May 9, 2008
Regulatory polymorphisms and their contribution to interindividual differences in the expression of enzymes influencing drug and toxicant dispositionRonald N Hines, Sevasti B Koukouritaki, Mark T Poch, et al.
Pediatric Research|January 26, 2002
Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expressionSevasti B Koukouritaki, Pippa Simpson, Catherine K Yeung, et al.
Molecular Pharmacology|April 29, 2005
Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variantsSevasti B Koukouritaki, Mark T Poch, Erwin T Cabacungan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 23, 2003
Human hepatic CYP2E1 expression during developmentElizabeth K Johnsrud, Sevasti B Koukouritaki, Karthika Divakaran, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2003
Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6)Ronald N Hines, Zhaohui Luo, Kathleen A Hopp, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 17, 2003
Developmental expression of the major human hepatic CYP3A enzymesJeffrey C Stevens, Ronald N Hines, Chungang Gu, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 25, 2003
Developmental expression of human hepatic CYP2C9 and CYP2C19Sevasti B Koukouritaki, Jason R Manro, Sandra A Marsh, et al.
The Journal of Biological Chemistry|February 5, 2025
Phosphorylation of distal C-terminal residues promotes TRPV4 channel activation in response to arachidonic acidAravind Parthasarathy, Andriy Anishkin, Yangjing Xie, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2011
Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogsJuan Fang, Eric S Jensen, Mary K Boudreaux, et al.
Pageof 2